| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | MAB72272-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-61909-0.1mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP2-62026B | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-25972 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80784 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18541-25ul | |||
| Azide and BSA Free | NBP3-44380 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38434-25ul | |||
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (CVID3/429) [NBP2-44675] - Immunofluorescent staining of Raji cells. CD19 Antibody (CVID3/429) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-429-Immunocytochemistry-Immunofluorescence-NBP2-44675-img0003.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (CVID3/429) [NBP2-44675] - Immunofluorescent staining of Raji cells. CD19 Antibody (CVID3/429) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)")
![Flow Cytometry: CD19 Antibody (CVID3/429) [NBP2-44675] - Flow cytometry analysis of lymphocyte-gated PBMCs unstained (gray) or stained with CF405S-labeled CD19 antibody (CVID3/429) (violet).](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-429-Flow-Cytometry-NBP2-44675-img0004.jpg)
![Flow Cytometry: CD19 Antibody (CVID3/429) [NBP2-44675] - Flow Cytometric Analysis of Raji cells. CD19 Antibody (CVID3/429) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-429-Flow-Cytometry-NBP2-44675-img0002.jpg)
![Immunohistochemistry: IgD Antibody (RM123) [Unconjugated] [NBP2-62026] - Immunohistochemistry of Human Lymphoid Tissue using NBP2-62026.](http://images.novusbio.com/fullsize/IgD-Antibody-RM123-Unconjugated-Immunohistochemistry-NBP2-62026-img0001.jpg "Immunohistochemistry: IgD Antibody (RM123) [Unconjugated] [NBP2-62026] - Immunohistochemistry of Human Lymphoid Tissue using NBP2-62026.")
![ELISA: IgD Antibody (RM123) - Azide and BSA Free [NBP2-62026] - ELISA of human immunoglobulins shows RM123 reacts to IgD from human plasma and IgD kappa from human myeloma. No cross reactivity with human IgG, IgM, IgA, or IgE. The plate was coated with 50 ng/well of different immunoglobulins. 200 ng/mL, 50ng/mL, or 10 ng/mL of RM123 was used as the primary antibody. An alkaline phosphatase conjugated anti-rabbit IgG as the secondary antibody.](http://images.novusbio.com/fullsize/nbp2-62026_rabbit-monoclonal-igd-antibody-rm123-elisa-189202523444722.png)
![ELISA: IgD Antibody (RM123) - Azide and BSA Free [NBP2-62026] - A titer ELISA using RM123. The plate was coated with different amounts of human IgD (from plasma). A serial dilution of RM123 was used as the primary antibody. An alkaline phosphatase conjugated anti-rabbit IgG as the secondary antibody.](http://images.novusbio.com/fullsize/nbp2-62026_rabbit-monoclonal-igd-antibody-rm123-elisa-18920252351213.png)
![Sandwich ELISA: IgD Antibody (RM123) - Azide and BSA Free [NBP2-62026] - Sandwich ELISA using RM123 as the capture antibody (100ng/well), and NBP3-18532 as the detection antibody, followed by an alkaline phosphatase conjugated streptavidin.](http://images.novusbio.com/fullsize/nbp2-62026_rabbit-monoclonal-igd-antibody-rm123-sandwich-elisa-189202523485311.png)
![Flow Cytometry: IgD Antibody (11-26c.2a) [NBP1-49000] - C57BL/6 mouse splenocytes stained with 11-26c.2a FITC](http://images.novusbio.com/fullsize/IgD-Antibody-11-26c-2a-Flow-Cytometry-NBP1-49000-img0001.jpg "Flow Cytometry: IgD Antibody (11-26c.2a) [NBP1-49000] - C57BL/6 mouse splenocytes stained with 11-26c.2a FITC")
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human tonsil shows moderate membranous positivity in germinal center cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0003.jpg "Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human tonsil shows moderate membranous positivity in germinal center cells.")
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human testis cancer (embryonal carcinoma) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0001.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human ovarian cancer (dysgeminoma) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0002.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human testis shows weak membranous and cytoplasmic positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0004.jpg)
![Western Blot: CD27/TNFRSF7 Antibody [NBP2-38434] - Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Human cell line Daudi](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-Western-Blot-NBP2-38434-img0002.jpg "Western Blot: CD27/TNFRSF7 Antibody [NBP2-38434] - Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Human cell line Daudi")
